Identification of Vimentin as a Potential Therapeutic Target against HIV Infection
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of Vimentin as a Potential Therapeutic Target against HIV Infection
Authors
Keywords
-
Journal
Viruses-Basel
Volume 8, Issue 6, Pages 98
Publisher
MDPI AG
Online
2016-06-16
DOI
10.3390/v8060098
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Maraviroc 150 mg daily plus lopinavir/ritonavir, a nucleoside/nucleotide reverse transcriptase inhibitor-sparing regimen for HIV-infected naive patients: 48-week final results of VEMAN study
- (2015) S. Nozza et al. CLINICAL MICROBIOLOGY AND INFECTION
- Hologram Quantitative Structure Activity Relationship, Docking, and Molecular Dynamics Studies of Inhibitors for CXCR4
- (2014) Chongqian Zhang et al. Chemical Biology & Drug Design
- Expansion of HAART Coverage Is Associated with Sustained Decreases in HIV/AIDS Morbidity, Mortality and HIV Transmission: The “HIV Treatment as Prevention” Experience in a Canadian Setting
- (2014) Julio S.G. Montaner et al. PLoS One
- Enhanced Cellular Uptake of Albumin-Based Lyophilisomes when Functionalized with Cell-Penetrating Peptide TAT in HeLa Cells
- (2014) Etienne van Bracht et al. PLoS One
- Translational HIV-1 research: from routine diagnostics to new virology insights in Amsterdam, the Netherlands during 1983-2013
- (2013) Antoinette C van der Kuyl et al. Retrovirology
- HIV-1 transcription and latency: an update
- (2013) Carine Van Lint et al. Retrovirology
- HIV-1 Assembly, Budding, and Maturation
- (2013) W. I. Sundquist et al. Cold Spring Harbor Perspectives in Medicine
- Host Factors and HIV-1 Replication: Clinical Evidence and Potential Therapeutic Approaches
- (2013) Mariana Santa-Marta et al. Frontiers in Immunology
- Anti-CD4 Monoclonal Antibody Ibalizumab Exhibits Breadth and Potency Against HIV-1, With Natural Resistance Mediated by the Loss of a V5 Glycan in Envelope
- (2012) Craig S. Pace et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Targeting the Human DEAD-Box Polypeptide 3 (DDX3) RNA Helicase as a Novel Strategy to Inhibit Viral Replication
- (2011) A. Garbelli et al. CURRENT MEDICINAL CHEMISTRY
- Proteomic Signatures of Human Oral Epithelial Cells in HIV-Infected Subjects
- (2011) Elizabeth Yohannes et al. PLoS One
- Antiviral activity of α-helical stapled peptides designed from the HIV-1 capsid dimerization domain
- (2011) Hongtao Zhang et al. Retrovirology
- How HIV Takes Advantage of the Cytoskeleton in Entry and Replication
- (2011) Bettina Stolp et al. Viruses-Basel
- HIV-1 Entry, Inhibitors, and Resistance
- (2010) Michael A. Lobritz et al. Viruses-Basel
- Host proteins involved in HIV infection: New therapeutic targets
- (2009) Nathalie Arhel et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- New approaches for quantitating the inhibition of HIV-1 replication by antiviral drugs in vitro and in vivo
- (2009) Moira A McMahon et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Onset of Human Cytomegalovirus Replication in Fibroblasts Requires the Presence of an Intact Vimentin Cytoskeleton
- (2009) M. S. Miller et al. JOURNAL OF VIROLOGY
- Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
- (2009) Mari M. Kitahata et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More